Many factors including pathology, age, level of tumor markers (Neuron‐specific enolase (NSE) and Carcinoembryonic antigen (CEA)) and tumor‐associated gene mutations have been identified to associate with brain metastasis. Here, ENO2 is linked to neoplasm.